PLGA microparticles encapsulating prostaglandin E 1- hydroxypropyl-β-cyclodextrin (PGE 1-HPβCD) complex for the treatment of Pulmonary Arterial Hypertension (PAH)
Research output: Contribution to journal › Article › peer-review
41Scopus
citations
Fingerprint
Dive into the research topics of 'PLGA microparticles encapsulating prostaglandin E 1- hydroxypropyl-β-cyclodextrin (PGE 1-HPβCD) complex for the treatment of Pulmonary Arterial Hypertension (PAH)'. Together they form a unique fingerprint.